Huang Y - Search Results

1

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC.

Zhao H, Huang Y, Shi J, Dai Y, Wu L, Zhou H. Zhao H, et al. Among authors: huang y. Front Pharmacol. 2018 Nov 20;9:1312. doi: 10.3389/fphar.2018.01312. eCollection 2018. Front Pharmacol. 2018. PMID: 30515095 Free PMC article.

2

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines.

Wen C, Xu G, He S, Huang Y, Shi J, Wu L, Zhou H. Wen C, et al. Among authors: huang y. J Cancer. 2020 Apr 6;11(13):3816-3826. doi: 10.7150/jca.39783. eCollection 2020. J Cancer. 2020. PMID: 32328186 Free PMC article.

3

Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer.

Shi J, Huang Y, Wen C, He S, Wu L, Zhou H. Shi J, et al. Among authors: huang y. Comput Biol Chem. 2020 May 19;87:107288. doi: 10.1016/j.compbiolchem.2020.107288. Online ahead of print. Comput Biol Chem. 2020. PMID: 32521497

4

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway.

Huang Y, Dai Y, Wen C, He S, Shi J, Zhao D, Wu L, Zhou H. Huang Y, et al. Mol Ther Nucleic Acids. 2020 Sep 4;21:885-899. doi: 10.1016/j.omtn.2020.07.027. Epub 2020 Jul 25. Mol Ther Nucleic Acids. 2020. PMID: 32805491 Free PMC article.

5

Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation.

Huang Y, Du Y, Zheng Y, Wen C, Zou H, Huang J, Zhou H, Zhao H, Wu L. Huang Y, et al. Among authors: huang j. Cell Death Dis. 2022 Jun 18;13(6):556. doi: 10.1038/s41419-022-05014-1. Cell Death Dis. 2022. PMID: 35717493 Free PMC article.

6

CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathway.

Wen C, Li Y, Huang Y, Wang N, He S, Bao M, Zhou H, Wu L. Wen C, et al. Among authors: huang y. Int J Biochem Cell Biol. 2023 Jan;154:106344. doi: 10.1016/j.biocel.2022.106344. Epub 2022 Dec 9. Int J Biochem Cell Biol. 2023. PMID: 36503048

7

Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer.

Wang N, Zhao Q, Huang Y, Wen C, Li Y, Bao M, Wu L. Wang N, et al. Among authors: huang y. Mol Omics. 2023 Mar 27;19(3):238-251. doi: 10.1039/d2mo00261b. Mol Omics. 2023. PMID: 36651104

8

Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway.

Xia WF, Zheng XL, Liu WY, Huang YT, Wen CJ, Zhou HH, Wu QC, Wu LX. Xia WF, et al. Cancer Gene Ther. 2024 May;31(5):778-789. doi: 10.1038/s41417-024-00760-0. Epub 2024 Mar 13. Cancer Gene Ther. 2024. PMID: 38480975

9

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer.

Li Y, Wang N, Huang Y, He S, Bao M, Wen C, Wu L. Li Y, et al. Among authors: huang y. Cancer Genet. 2024 Jun;284-285:34-42. doi: 10.1016/j.cancergen.2024.04.001. Epub 2024 Apr 15. Cancer Genet. 2024. PMID: 38626533

10

Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis.

Huang Y, Wang X, Wen C, Wang J, Zhou H, Wu L. Huang Y, et al. MedComm (2020). 2024 Jul 20;5(8):e653. doi: 10.1002/mco2.653. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39036343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,726 results

Search Page

Filters